Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $4.81 million. The enterprise value is $3.71 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 1.63 million shares outstanding. The number of shares has increased by 922.94% in one year.
| Current Share Class | 1.63M |
| Shares Outstanding | 1.63M |
| Shares Change (YoY) | +922.94% |
| Shares Change (QoQ) | +37.80% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 4.32% |
| Float | 1.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.86 |
| P/TBV Ratio | 6.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.85 |
Financial Efficiency
Return on equity (ROE) is -1,401.39% and return on invested capital (ROIC) is -839.20%.
| Return on Equity (ROE) | -1,401.39% |
| Return on Assets (ROA) | -273.31% |
| Return on Invested Capital (ROIC) | -839.20% |
| Return on Capital Employed (ROCE) | -1,615.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.12M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.64% in the last 52 weeks. The beta is -0.80, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.80 |
| 52-Week Price Change | -94.64% |
| 50-Day Moving Average | 9.02 |
| 200-Day Moving Average | 12.87 |
| Relative Strength Index (RSI) | 38.70 |
| Average Volume (20 Days) | 306,911 |
Short Selling Information
The latest short interest is 265,402, so 16.26% of the outstanding shares have been sold short.
| Short Interest | 265,402 |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 16.26% |
| Short % of Float | 16.28% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.33M |
| Pretax Income | -17.05M |
| Net Income | -16.77M |
| EBITDA | -16.33M |
| EBIT | -16.33M |
| Earnings Per Share (EPS) | -$37.32 |
Full Income StatementBalance Sheet
The company has $1.10 million in cash and n/a in debt, giving a net cash position of $1.10 million or $0.68 per share.
| Cash & Cash Equivalents | 1.10M |
| Total Debt | n/a |
| Net Cash | 1.10M |
| Net Cash Per Share | $0.68 |
| Equity (Book Value) | 767,807 |
| Book Value Per Share | 0.76 |
| Working Capital | -836,605 |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.31M |
| Capital Expenditures | n/a |
| Free Cash Flow | -14.31M |
| FCF Per Share | -$8.77 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
